Novavax completes process for WHO emergency use approval of COVID-19 vaccine

Vaccine developer Novavax Inc said on Thursday it has completed the submission process for emergency use listing of its COVID-19 vaccine candidate with the World Health Organization.

Related Keywords

New York ,United States ,Maryland ,Philippines ,Indonesia ,India ,Bengaluru ,Karnataka ,Stanley Erck ,Carl Odonnell ,Arun Koyyur ,Mrinalika Roy ,Thomson Reuters Trust Principles ,World Health Organization ,Reuters ,Novavax Inc ,World Health ,Chief Executive Stanley Erck ,Carlo Donnell ,Thomson Reuters Trust ,Mtpix ,Cmpny ,Covid ,Gen ,Genhlt ,Hea ,Heca ,Humdis ,Infdis ,Medst ,Mrch ,Mrch1 ,Phar ,Phar08 ,Phmr ,Pxp ,Vaccin ,Gamers ,Us ,Namer ,Topnws ,Intag ,Regs ,Topcmb ,Un1 ,Bact ,Moms ,Pres ,Resf ,